BMC Cardiovascular Disorders

NEW Call for papers: Recent innovations and barriers in managing cardiovascular disorders

BMC Cardiovascular Disorders is pleased to welcome submissions to this thematic series. All work highlighting current progress and challenges in the diagnosis and treatment of cardiovascular disorders will be considered.

Announcement: we are recruiting new Associate Editors

We are recruiting new Associate Editors to join our international Editorial Board, helping to provide expertise on a wide range of subjects within the area of disorders of the heart and circulatory system

Did your research give you data you couldn't find a home for?

Perhaps the outcome was unexpected? Or maybe you haven't had a chance to analyse it? Or it just didn't make it into the final paper?

Interesting data often gets overlooked. By publishing it as a data note in BMC Research Notes it can be found in PubMed, SCImago, Scopus and other indexing services.

Find out which formats we accept and how easy it is to free your data.

Highlights from European Society of Cardiology Congress 2019

BMC Cardiovascular Disorders traveled to Paris to attend the European Society of Cardiology (ESC) 2019 Congress held together with the World Congress of Cardiology. The overarching theme communicated to nearly 33,000 health professional delegates from 146 different countries was “Global cardiovascular health”. Editor Ciarán Fitzpatrick highlight some of our most impactful moments from Congress.

Reviewer acknowledgements

The editors and staff of BMC Cardiovascular Disorders would like to warmly thank the reviewers whose comments helped to shape the journal, for their invaluable assistance with review of manuscripts in Volume 18 (2018).

Sudden Cardiac Death - advances in diagnosis and treatment

Read the published content in this thematic series covering all aspects of research into Sudden Cardiac Death from next-generation sequencing methods to eHealth-based interventions.

Tianxiao Huan, Section Editor

Dr. Huan has been working in the Population Sciences Branch, Framingham Heart Study, and National Heart, Lung and Blood Institute (NHLBI), USA, for nearly a decade using high throughput genetics and multi-omics data